Company / Current Liabilities per Share
Gilead Sciences Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$9.48
FY2025
5-year range
$8.96 / $9.63
FY2021-FY2025
Trend
-1.6%
vs FY2024
Sector context
#24 of 210
Health Care
What the data says
Gilead Sciences's current liabilities per share of $9.48 is higher than 89% of companies in the Health Care sector (FY2025). Current Liabilities per Share has fluctuated over the past 10 years, ranging from $6.48 in FY2016 to $9.63 in FY2024.
Based on SEC 10-K filings.
9.48 in FY2025 with a 5-year CAGR of +1.0%. Top quartile in the Health Care sector.
Increased from $9.05 to $9.48 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +1.9%
- 5-Year CAGR
- +1.0%
- 10-Year CAGR
- -
Sector benchmark
-60.1% below sector average
Key checks
Key Insights
- In FY2025, current liabilities per share decreased 1.6% year-over-year.
- Ranks #24 out of 210 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2024.
- Lowest current liabilities per share in the period was in FY2016.
Company context
Key Data Points
- Strong profit margin: 27.9%
- Strong return on equity: 37.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.48 | -1.6% |
| FY2024 | $9.63 | +6.5% |
| FY2023 | $9.05 | +0.9% |
| FY2022 | $8.96 | -3.2% |
| FY2021 | $9.26 | +2.8% |
| FY2020 | $9.00 | +18.3% |
| FY2019 | $7.61 | -6.1% |
| FY2018 | $8.11 | -8.7% |
| FY2017 | $8.88 | +37.0% |
| FY2016 | $6.48 | -1.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026